LncRNA microarray profiling identifies novel circulating lncRNAs in hidradenitis suppurativa.
Mol Med Rep
; 30(1)2024 Jul.
Article
em En
| MEDLINE
| ID: mdl-38757342
ABSTRACT
Long noncoding RNAs (lncRNAs) have been demonstrated to be involved in biological processes, both physiological and pathological, including cancer, cardiovascular diseases, multiple sclerosis, autoimmune hepatitis and types I and II diabetes. LncRNAs are also known to have a critical role in the physiology of skin, and in the pathology of cutaneous diseases. LncRNAs are involved in a wide range of biological activities, including transcriptional posttranscriptional processes, epigenetics, RNA splicing, gene activation and or silencing, modifications and/or editing; therefore, lncRNAs may be useful as potential targets for disease treatment. Hidradenitis suppurativa (HS), also termed acne inversa, is a major skin disease, being an inflammatory disorder that affects ~1% of global population in a chronic manner. Its pathogenesis, however, is only partly understood, although immune dysregulation is known to have an important role. To investigate the biological relevance of lncRNAs with HS, the most differentially expressed lncRNAs and mRNAs were first compared. Furthermore, the lncRNAmicroRNA regulatory network was also defined via reverse transcriptionquantitative PCR analysis, whereby a trio of lncRNA expression signatures, lncRNATINCR, lncRNARBM5ASI1 and lncRNAMRPL23AS1, were found to be significantly overexpressed in patients with HS compared with healthy controls. In conclusion, the three lncRNAs isolated in the present study may be useful for improving the prognostic prediction of HS, as well as contributing towards an improved understanding of the underlying pathogenic mechanisms, thereby potentially providing new therapeutic targets.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Hidradenite Supurativa
/
Perfilação da Expressão Gênica
/
Redes Reguladoras de Genes
/
RNA Longo não Codificante
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article